focus -WSS

focus

author：hotspot 2025-09-28 20:31:58 - browse：86

MultiPlan is facing a new class action lawsuit that alleges the company and large health insurers “conspired to fix, suppress, and stabilize” payments made for out-of-network medical claims.

The lawsuit, filed by for-profit hospital company Allegiance Health Management, builds on the contentious relationship between hospitals and MultiPlan, a data technology vendor that works with the biggest insurers to determine how much should be paid for care that is delivered outside of an insurance network. It comes just weeks after the New York Times published an investigation detailing how MultiPlan and its insurance company clients make more money by low-balling payments to hospitals.

The lawsuit further lays bare some of the warped incentives that exist within the health care system: out-of-network providers billing inflated amounts, insurers profiting by making sure those payments are as low as possible, and patients stuck in the middle with bills they often cannot afford.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： The drug industry has found itself all alone in Washington

explore

WSS

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Readout LOUD podcast: Venture capital turmoil, obesity drug competition

The problem with charging patients to message their doctors

MD Anderson's Padmanee Sharma responds to research credit suit

First medicine developed to treat MASH expected to be approved soon

Novo Nordisk obesity pill bests Wegovy in early trial

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Jerome Adams on the need for new antivirals for Covid

New CMS data security rules will hurt Medicare, Medicaid research

Medical leaders decry Supreme Court decision on affirmative action

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

Peter Hotez and the public health issue of online harassment

FDA warns medical device makers about rise in fabricated data

Wildfire smoke exposes gaps in outdoor worker protections

In surprise move, FDA calls for advisory committee on Lilly's Alzheimer's drug

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Wikipedia

Precocious puberty in girls comes with mental health risks

NEJM study link tiny plastics in blood vessels to heart problems

With psoriasis trial ahead, Alumis raises $259 million

Change Healthcare payments predicted restored March 15

Amylyx ALS drug fails large clinical trial

In 'major milestone,' FDA approves first cell therapy for solid tumors

focus

explore

focus

hotspot